Eli Lilly
Eli Lilly researches, develops and manufactures pharmaceutical products at its own and third-party facilities, which places it in the metabolic pool's layer of GLP-1 (glucagon-like peptide-1) drug manufacturers.
Revised after a check against the company's own annual filing.
Latest disclosed
10-Q filed 2026-08-05 · period ending 2026-06-30
Pieces naming this company
None yet.
No price is shown: the Index is a map of what each company sells and where it sits, not a quote board.